medical cannabis

Showing 6 posts of 6 posts found.

Medical cannabis formulation kills prostate cancer in laboratory tests

July 19, 2021
Sales and Marketing medical cannabis, prostate cancer

Apollon Formularies have announced its medical cannabis formulations were shown to be effective in killing both hormone-resistant and hormone-sensitive prostate …

Medical cannabis formulation kills breast cancer cells in trial

June 28, 2021
Sales and Marketing breast cancer, medical cannabis, oncology

UK-based pharma company, Apollon Formularies, have announced that their medical cannabis formulations were successful in killing triple-negative breast cancer (TNBC) …

Medical cannabis more effective painkiller in 86% of chronic pain patients

May 27, 2021
medical cannabis

The Medical Cannabis Clinics (TMCC) have released new data from a survey of patients prescribed medical cannabis to treat pain, …

Medical cannabis: Growth by leaps and bounds

October 18, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Canada, Canopy Growth, medical cannabis, pharma

This article follows parts one and two of our trio of in-depth pieces focusing on the growing medical cannabis phenomenon. …

_dsc6281_1

Medical cannabis: Riding the wave

October 16, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kanabo research, medical cannabis, pharma

Following on from our previous piece from Mewburn Ellis on the history of social attitudes towards cannabis, Israel-based Kanabo Research …

_dsc6538

Medical cannabis: On to greener pastures?

October 14, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing medical cannabis, medicinal cannabis, pharma

In the first of three articles on the topic, Callum McGuinn, Associate and European Patent Attorney at Mewburn Ellis, explores …

Latest content